×
ePlus investor relations, including stock and financial information, press releases, and leadership. ePlus inc. is listed on NASDAQ Global Markets.
Regulatory News Company Reports & Presentations Fact Sheet. Investor Relations. LON:PLUS £1,628.87M. 2092.00p (-0.38%) April 19, 2024 | 16:35 GMT. FY 2023. KEY ...
The Investor Relations website contains information about Plus Therapeutics Inc.'s business for stockholders, potential investors, and financial analysts.
People also ask
Investor Presentations Earnings Conference Call Transcripts Annual Meeting & Proxy · Home + Investor Relations + Investor Presentations ... NASDAQ: PLUS. Contact ...
The Investor Relations website contains information about SP Plus Corporation's business for stockholders, potential investors, and financial analysts.
Simulations Plus, Inc. is the leading developer of ADMET, PBPK, and PBBM modeling and simulation software for research and development.
View our Financial Reports. Investor Contact Information. Investor Relations. Adam Kurnik Director, Corporate Finance & Investor Relations Tel: 416-340-6006
Investor Resources. For institutional analysts and investor inquiries, please contact Investor Relations mailbox or (312)-394-2345.
Investor Relations Plus (IR+) facilitates and accelerates efforts of IR and PR professionals wherever needed and provides a highly effective turn-key solution ...
Investor Relations. Alammenüü. News · Reports and presentations · Key Financials · Financial Calendar. Regular reports: PlusPlus Capital Monthly Report ...